L. Bernardi et al. / Tetrahedron 62 (2006) 375–380
379
1
128.6, 128.9, 129.2, 135.8, 136.4, 155.4; ESIMS m/z 323
[MCNaC]; [a]D22 C5 (c 0.348, CHCl3), 84% ee.
0.68 (n-hexane/EtOAc, 7:3); mp 128–131 8C; H NMR d
1.44 (s, 9H), 4.68 (dd, JZ5.0, 12.6 Hz, 1H), 4.76–4.9 (br s,
1H), 5.28–5.40 (br s, 2H), 7.23–7.27 (m, 2H), 7.34–7.37 (m,
2H); 13C NMR d 28.2, 52.2, 78.6, 80.9, 127.7, 129.4, 134.6,
135.4, 154.6; ESIMS m/z 323 [MCNaC]; [a]D22 C20
(c 0.790, CHCl3), 94% ee.
4.2.2. (S)-2-Nitro-1-phenylethyl carbamic acid t-butyl
ester (2b). Following the general procedure, compound 2b
was obtained as a white solid in 72% yield. The ee of the
product was determined by HPLC using a Daicel Chiralpak
AD-H column (n-hexane/i-PrOHZ95:5, flow rate 0.75 mL/
min, tmajorZ36.0 min; tminorZ38.2 min). [a]2D2 C14
4.2.7. 1-(p-Chlorophenyl)-2-nitroethyl carbamic acid
benzyl ester (2k). Following the general procedure,
compound 2k was obtained as a yellow oil in 58% yield.
The ee of the product was determined by HPLC using a
Daicel Chiralpak AD-H column (n-hexane/i-PrOHZ90:10,
1
(c 0.578, CHCl3), 88% ee. The H and 13C NMR spectra
and mp are consistent with values previously reported in the
literature.10
flow rate 0.75 mL/min, tmajorZ36.7 min; tminor
Z
59.0 min). Rf 0.45 (n-hexane/EtOAc, 7:3); 1H NMR d
4.68 (dd, JZ5.1, 12.7 Hz, 1H), 4.76–4.89 (br s, 1H), 5.10 (s,
2H), 5.36–5.45 (br s, 1H), 5.63–5.71 (br s, 1H), 7.20–7.41
(m, 9H); 13C NMR d 52.6, 67.5, 78.3, 127.7, 128.4, 128.6,
128.9, 129.4, 129.9, 134.8, 135.7, 155.3; ESIMS m/z 357
[MCNaC]; [a]D22 C8 (c 0.160, CHCl3), 90% ee.
4.2.3. (9-H-Fluoren-9-yl)methyl 2-nitro-1-phenylethyl-
carbamate (2c). Following the general procedure, com-
pound 2c was obtained as a white solid in 60% yield. The ee
of the product was determined by HPLC using a Daicel
Chiralpak AD-H column (n-hexane/i-PrOHZ80:20, flow
rate 0.75 mL/min, tmajorZ23.7 min; tminorZ42.3 min). Rf
1
0.51 (n-hexane/EtOAc, 7:3); mp 148–150 8C; H NMR d
4.20 (t, JZ6.6 Hz, 1H), 4.38–4.62 (br s, 2H), 4.62–4.94 (br
s, 2H), 5.36–5.60 (br s, 2H), 7.22–7.64 (m, 11H), 7.66 (d,
JZ7.6 Hz, 2H); 13C NMR d 47.1, 53.1, 67.1, 78.4, 120.0,
124.9, 126.3, 127.1, 127.8, 128.8, 129.3, 136.4, 141.3,
143.6, 155.4; ESIMS m/z 411 [MCNaC]; [a]D22 C11 (c
0.675, CHCl3), 90% ee.
4.2.8. 1-(o-Bromophenyl)-2-nitroethyl carbamic acid
t-butyl ester (2l). Following the general procedure,
performing the reaction at K40 8C, compound 2l was
obtained as a white solid in 82% yield. The ee of the product
was determined by HPLC using a Daicel Chiralpak AD-H
column (n-hexane/i-PrOHZ90:10, flow rate 1 mL/min,
tmajorZ18.4 min; tminorZ12.9 min). Rf 0.60 (n-hexane/
EtOAc, 7:3); mp 130–133 8C; 1H NMR d 1.43 (s, 9H), 4.72–
4.92 (br s, 2H), 5.64–5.76 (br s, 2H), 7.20 (dt, JdZ8.0 Hz,
JtZ4.5 1H), 7.34 (d, JZ4.2 Hz, 2H), 7.59 (dt, JdZ7.9 Hz,
JtZ0.9 Hz, 1H); 13C NMR d 28.2, 52.4, 77.5, 80.8, 122.7,
127.9, 128.1, 130.1, 133.6, 135.9, 154.5; ESIMS m/z 367
[MCNaC]; [a]D22 K8 (c 0.402, CHCl3), 88% ee.
4.2.4. 1-(1-Naphthyl)-2-nitroethyl carbamic acid t-butyl
ester (2h). Following the general procedure, compound 2h
was obtained as a white solid in 87% yield. The ee of the
product was determined by HPLC using a Daicel Chiralpak
AD-H column (n-hexane/i-PrOHZ90:10, flow rate 1 mL/
min, tmajorZ17.0 min; tminorZ25.7 min). Rf 0.64
1
(n-hexane/EtOAc, 7:3); mp 174–177 8C; H NMR d 1.43
(s, 9H), 4.80–4.98 (br s, 2H), 5.24–5,38 (br s, 1H),
6.22–6.34 (br s, 1H), 7.44–7.48 (m, 2H), 7.52–7.58 (m,
1H), 7.60–7.64 (m, 1H), 7.84–7.86 (m, 1H), 7.88–7.92 (m,
1H), 8.11–8.13 (m, 1H); 13C NMR d 28.2, 49.2, 78.2, 80.8,
122.2, 123,2, 125.2, 126.3, 127.3, 129.2, 129.5, 130.3,
132.6, 134.1, 154.7; ESIMS m/z 339 [MCNaC]; [a]D22 C7
(c 0.498, CHCl3), 88% ee.
4.2.9. 1-(p-Methoxyphenyl)-2-nitroethyl carbamic acid
t-butyl ester (2m). Following the general procedure,
compound 2m was obtained as a white solid in 65% yield.
The ee of the product was determined by HPLC using a
Daicel Chiralpak AD-H column (n-hexane/i-PrOHZ98:2,
flow rate 1 mL/min, tmajorZ91.6 min; tminorZ97.5 min). Rf
1
0.53 (n-hexane/EtOAc, 7:3); mp 141–144 8C; H NMR d
1.44 (s, 9H), 3.80 (s, 3H), 4.66 (dd, JZ5.9, 12.4 Hz, 1H),
4.75–4.9 (br s, 1H), 5.14–5.24 (br s, 1H), 5.25–5.35 (br s,
1H), 6.89 (d, JZ8.8 Hz, 2H), 7.22 (d, JZ8.8 Hz, 2H); 13C
NMR d 28.2, 52.4, 55.3, 78.9, 80.6, 114.5, 127.6, 128.8,
154.7, 159.8; ESIMS m/z 319 [MCNaC]; [a]D22 C28 (c
0.693, CHCl3), 82% ee.
4.2.5. 1-(2-Naphthyl)-2-nitroethyl carbamic acid t-butyl
ester (2i). Following the general procedure, performing the
reaction at K40 8C, compound 2i was obtained as a white
solid in 82% yield. The ee of the product was determined by
HPLC using a Daicel Chiralpak AD-H column (n-hexane/
i-PrOHZ90:10, flow rate 1 mL/min, tmajorZ17.8 min;
tminorZ21.5 min). Rf 0.79 (n-hexane/EtOAc, 7:3); mp
4.2.10. 2-Nitro-1-(thiophen-2-yl)ethyl carbamic acid
t-butyl ester (2n). Following the general procedure,
compound 2n was obtained as a yellow oil in 50% yield.
The ee of the product was determined by HPLC using a
Daicel Chiralpak AD-H column (n-hexane/i-PrOHZ98:2,
flow rate 1 mL/min, tmajorZ54.0 min; tminorZ57.4 min). Rf
1
144–146 8C; H NMR d 1.45 (s, 9H), 4.80 (dd, JZ5.5,
12.6 Hz, 1H), 4.88–5.00 (br s, 1H), 5.34–5.46 (br s, 1H),
5.50–5.60 (br s, 1H), 7.40 (dd, JZ1.8, 8.5 Hz, 1H), 7.48–
7.54 (m, 2H), 7.76 (m, 1H), 7.82–7.88 (m, 3H); 13C NMR d
28.3, 53.0, 78.8, 80.8, 123.7, 125.6, 126.7, 126.7, 127.7,
128.0, 129.2, 133.2, 133.2, 134.2, 154.8; ESIMS m/z 339
[MC NaC]; [a]D22 C38 (c 0.505, CHCl3), 94% ee.
1
0.52 (n-hexane/EtOAc, 7:3); H NMR d 1.46 (s, 9H), 4.75
(dd, JZ5.6, 12.9 Hz, 1H), 4.84–4.98 (br s, 1H), 5.22–5.36
(br s, 1H), 5.56–5.70 (br s, 1H), 6.97–7.02 (m, 2H), 7.27–
7.29 (m, 1H); 13C NMR d 28.2, 48.9, 77.3, 78.6, 81.0, 125.7,
127.3, 140.0, 154.4; ESIMS m/z 295 [MCNaC]; [a]D22 C12
(c 0.445, CHCl3), 82% ee.
4.2.6. 1-(p-Chlorophenyl)-2-nitroethyl carbamic acid
t-butyl ester (2j). Following the general procedure,
compound 2j was obtained as a white solid in 77% yield.
The ee of the product was determined by HPLC using a
Daicel Chiralpak AD-H column (n-hexane/i-PrOHZ90:10,
flow rate 1 mL/min, tmajorZ12.8 min; tminorZ16.1 min). Rf
4.2.11. 1-(Furan-2-yl)-2-nitro-ethyl carbamic acid
t-butyl ester (2o). Following the general procedure,